Literature DB >> 19230641

Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension.

Nabil Saouti1, Frances de Man, Nico Westerhof, Anco Boonstra, Jos Twisk, Pieter E Postmus, Anton Vonk Noordegraaf.   

Abstract

INTRODUCTION: Recent studies suggest that medically treated patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) have an improved prognosis. However, only limited data are available concerning predictors of mortality in these patients. The aim of this study was to assess, and to identify, predictors of the long-term outcome of inoperable CTEPH patients.
METHODS: We analysed 84 inoperable CTEPH patients referred to our centre between 1999 and 2008. During follow-up (mean 32 months), 17 patients died and one underwent a lung transplantation. The 1-, 3- and 5-year survival rates were 93, 78 and 68%, respectively. Univariate analysis demonstrated that 6-min walking distance (6MWD), mean pulmonary artery pressure (mPAP), right atrial pressure (RAP) and pulmonary vascular resistance (PVR) were predictive factors for survival. In the multivariate analysis only 6MWD was independently related to poor survival (hazard ratio 0.995; 95% CI, 0.991-0.998; P=0.003). Kaplan-Meier curves showed that patients with an mPAP>40 mmHg, PVR>584 dyn s cm(-5) and RAP>12 mmHg had a very poor prognosis.
CONCLUSIONS: Haemodynamic parameters (mPAP, RAP, PVR) and the 6MWD at baseline are predictive factors for mortality of medically treated inoperable CTEPH patients. A subgroup of these patients with good prognostic factors, defined by their haemodynamics and clinical measures, have an improved long-term survival and outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230641     DOI: 10.1016/j.rmed.2009.01.017

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

1.  Clinical worsening during long-term follow-up in inoperable chronic thromboembolic pulmonary hypertension.

Authors:  Bastiaan E Scholzel; Martijn C Post; H W Thijs Plokker; Repke J Snijder
Journal:  Lung       Date:  2011-12-08       Impact factor: 2.584

2.  Hypertension: Surgery remains treatment of choice for CTEPH.

Authors:  Anton Vonk Noordegraaf; Harm J Bogaard
Journal:  Nat Rev Cardiol       Date:  2016-03-10       Impact factor: 32.419

3.  A Feasibility Study on Using Single-Photon Emission Computed Tomography Pulmonary Perfusion/Ventilation Imaging for the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension and Patient Risk Assessment.

Authors:  Rong-Zheng Ma; Ping-Ping Han; Xin-Cao Tao; Huan Li; Ling Wang; Zhen-Guo Zhai; Li-Ping Fu
Journal:  Int J Gen Med       Date:  2021-11-10

4.  Prognostic Value of Pulmonary Artery Pulsatility Index in Right Ventricle Failure-Related Mortality in Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Sylwia Sławek-Szmyt; Aleksander Araszkiewicz; Stanisław Jankiewicz; Marek Grygier; Tatiana Mularek-Kubzdela; Maciej Lesiak
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

5.  Exercise capacity affects quality of life in patients with pulmonary hypertension.

Authors:  Michael Halank; Franziska Einsle; Stephanie Lehman; Hinrich Bremer; Ralf Ewert; Heinrike Wilkens; F Joachim Meyer; Ekkehard Grünig; Hans-Jürgen Seyfarth; Martin Kolditz; Gesine Wieder; Gert Höffken; Volker Köllner
Journal:  Lung       Date:  2013-05-17       Impact factor: 2.584

6.  Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

Authors:  Nick H Kim; Andrea M D'Armini; Friedrich Grimminger; Ekkehard Grünig; Marius M Hoeper; Pavel Jansa; Eckhard Mayer; Claus Neurohr; Gérald Simonneau; Adam Torbicki; Chen Wang; Arno Fritsch; Neil Davie; Hossein-Ardeschir Ghofrani
Journal:  Heart       Date:  2016-12-23       Impact factor: 5.994

7.  Correlation Between Perfusion Abnormalities Extent in Ventilation/Perfusion SPECT/CT with Hemodynamic Parameters in Patients with Chronic Thromboembolic Pulmonary Hypertension

Authors:  Salih Özgüven; Selin Kesim; Kevser Öksüzoğlu; Mehmed Yanartaş; Serpil Taş; Feyza Şen; Tunç Öneş; Sabahat İnanır; Halil Turgut Turoğlu; Bülent Mutlu; Tanju Yusuf Erdil; Bedrettin Yıldızeli
Journal:  Mol Imaging Radionucl Ther       Date:  2021-02-09

8.  Sex and survival following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Scandinavian observational cohort study.

Authors:  Janica Kallonen; Kasper Korsholm; Fredrik Bredin; Matthias Corbascio; Mads Jønsson Andersen; Lars Bo Ilkjær; Søren Mellemkjær; Ulrik Sartipy
Journal:  Pulm Circ       Date:  2021-10-27       Impact factor: 3.017

9.  Riociguat Improves Pulmonary Hemodynamics in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Cheng-Hsuan Tsai; Cho-Kai Wu; Ping-Hung Kuo; Hsao-Hsun Hsu; Zheng-Wei Chen; Juey-Jen Hwang; Chi-Lun Ko; Yu-Sen Huang; Yen-Hung Lin
Journal:  Acta Cardiol Sin       Date:  2020-01       Impact factor: 2.672

10.  Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension.

Authors:  Christian Nagel; Felix Prange; Stefan Guth; Jochen Herb; Nicola Ehlken; Christine Fischer; Frank Reichenberger; Stephan Rosenkranz; Hans-Juergen Seyfarth; Eckhard Mayer; Michael Halank; Ekkehard Grünig
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.